Artificial
intelligence has firmly established itself in the world of medicine. This time, with the help of AI, neurosurgeons in London were able to save the vision of a 48-year-old patient by removing a brain tumor. 

The medical team used AI technology for the first time that could identify and highlight critical anatomical structures in different colors. This helped the surgeons avoid damaging them while removing the tumor—a tumor measuring just 11 millimeters in a particularly sensitive area. A potential complication, as doctors point out, could lead to blindness, a stroke, or death. “It is

designed to identify critical anatomical structures, surgical instruments, and interactions with tissues in real time, supporting the surgeon during extremely delicate procedures.”
 _{Dr. Sofia Bano – Associate Professor of Robotics and Artificial Intelligence at UCL}

The 48-year-old man had been diagnosed with the condition two years ago. His condition gradually worsened, causing him serious vision problems. Doctors recommended surgery, as without it there was a serious risk that he would lose his sight. The result was impressive. Within a week, he was able to get around without a cane or glasses.

“When I came to, I could see everything in the room clearly. I feel like I have a 360-degree panoramic view of everything around me.”
_{Reese Hibbert – Patient}

Groundbreaking Drug

New medical news regarding pancreatic cancer is generating optimism. The U.S. Food and Drug Administration has approved a groundbreaking drug for the most common—and also the deadliest—form of pancreatic cancer.  

The latest data from the American Cancer Society reveal the scale of the problem, as approximately 67,000 new cases are expected to be diagnosed in the U.S. this year, while more than 52,000 people are estimated to die from the disease.

This is the first pill that targets the protein that fuels tumor growth in more than 90% of pancreatic cancer cases. 500 patients with metastatic cancer received the drug and were found to have a median survival of 13.2 months, compared to 6.7 months for those who underwent chemotherapy. Another positive finding was the occurrence of fewer serious side effects

.”“This isn’t a cure, but it’s another option for these patients. However, it’s the best option we’ve ever had.”
_{Dr. Pashtoon Kasi – City of Hope}, _{Orange County}, _California

The pharmaceutical company behind this groundbreaking treatment is already exploring other treatments for cancers such as lung cancer.  

Watch the report by Nasia Ioannou: